Latest filing published 07 Jul 2020 for ENDONOVO THERAPEUTICS, INC., €18.
Filing timeline
BuySaleFirst 200 filings with a declared amount
Insider track record
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Alan Brian Collier: trading record in brief
All filings by Alan Brian Collier on record concern Endonovo Therapeutics, Inc. We count 769 filings; the first trade dates from 15 June 2015 and the latest from 1 July 2020.
On the market, this insider has only ever bought: 769 purchases, €67k in total. No amount is published for 4 filings, which the totals therefore leave out. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Since January 2020: 15 purchases and no sales on the market.
A typical purchase (the median) is worth €58. None of the 4 purchases we analysed coincided with buying by another insider of the same company within 30 days.
The latest filing, published on 7 July 2020, reports an open-market purchase of €18 in Endonovo Therapeutics, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 4 days. Section 16 rules allow two business days to file each Form 4. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Alan Brian Collier
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 200 shares@ US$0.10351.3% of flowCommon StockSEC:0001645470-20-000005:0Canonical exit: 28 Sept 2020 (T+90)
- 100 shares@ US$0.10040.7% of flowCommon StockSEC:0001645470-20-000005:1Canonical exit: 29 Sept 2020 (T+90)
- 100 shares@ US$0.10240.7% of flowCommon StockSEC:0001645470-20-000005:2Canonical exit: 29 Sept 2020 (T+90)
- 100 shares@ US$0.96490.8% of flowCommon StockSEC:0001645470-20-000004:0Canonical exit: 22 May 2020 (T+90)
- 100 shares@ US$1.50Common StockSEC:0001645470-20-000002:6Canonical exit: 19 Mar 2020 (T+90)
- 100 shares@ US$2.25Common StockSEC:0001645470-20-000001:0Canonical exit: 29 Mar 2020 (T+90)
- 100 shares@ US$1.75Common StockSEC:0001645470-20-000001:1Canonical exit: 1 Apr 2020 (T+90)
- 2,000 shares@ US$0.0028Common StockSEC:0001645470-19-000057:0Canonical exit: 9 Mar 2020 (T+90)
- 1,000 shares@ US$0.0025Common StockSEC:0001645470-19-000057:1Canonical exit: 9 Mar 2020 (T+90)
- 1,000 shares@ US$0.002Common StockSEC:0001645470-19-000057:2Canonical exit: 10 Mar 2020 (T+90)
- 100 shares@ US$0.0019Common StockSEC:0001645470-19-000057:3Canonical exit: 10 Mar 2020 (T+90)
- 1,000 shares@ US$0.0022Common StockSEC:0001645470-19-000057:4Canonical exit: 11 Mar 2020 (T+90)
- 500 shares@ US$0.0015Common StockSEC:0001645470-19-000057:5Canonical exit: 15 Mar 2020 (T+90)
- 100 shares@ US$0.0015Common StockSEC:0001645470-19-000057:6Canonical exit: 19 Mar 2020 (T+90)
- 2,000 shares@ US$0.0035Common StockSEC:0001645470-19-000056:0Canonical exit: 23 Feb 2020 (T+90)
- 1,000 shares@ US$0.0035Common StockSEC:0001645470-19-000056:1Canonical exit: 25 Feb 2020 (T+90)
- 2,000 shares@ US$0.0035Common StockSEC:0001645470-19-000056:2Canonical exit: 25 Feb 2020 (T+90)
- 2,000 shares@ US$0.0029Common StockSEC:0001645470-19-000056:3Canonical exit: 27 Feb 2020 (T+90)
- 2,000 shares@ US$0.0029Common StockSEC:0001645470-19-000056:4Canonical exit: 1 Mar 2020 (T+90)
- 2,000 shares@ US$0.0029Common StockSEC:0001645470-19-000056:5Canonical exit: 3 Mar 2020 (T+90)
- 2,000 shares@ US$0.0028Common StockSEC:0001645470-19-000056:7Canonical exit: 4 Mar 2020 (T+90)
- 1,000 shares@ US$0.0037Common StockSEC:0001645470-19-000055:0Canonical exit: 18 Feb 2020 (T+90)
- 1,000 shares@ US$0.0038Common StockSEC:0001645470-19-000055:1Canonical exit: 20 Feb 2020 (T+90)
- 2,000 shares@ US$0.0071Common stockSEC:0001645470-19-000054:0Canonical exit: 9 Feb 2020 (T+90)
- 200 shares@ US$0.0095Common StockSEC:0001645470-19-000053:0Canonical exit: 15 Jan 2020 (T+90)
25 of 704 declarations